102,428 Orion Corporation A shares converted into B shares

ORION COMPANY
EXIT ON THE STOCK EXCHANGE
DECEMBER 10, 2021 at 9.00 EET

102,428 Orion Corporation A shares converted into B shares

In accordance with section 3 of the Articles of Association of Orion Corporation, 102,428 A shares were converted into 102,428 B shares. The conversion was entered in the Commercial Register on December 10, 2021.

The total number of Orion Corporation shares is 141,134,278 which, after the conversion, consists of 34,813,206 A shares and 106,321,072 B shares. The number of votes of the shares of the company is after the conversion of 802 585 192.

Orion Company

Jari karlson

CFO

Olli huotari

Senior Vice-President, Corporate Functions

Contact:
Tuukka Hirvonen, Investor Relations, tel. +358 10 426 2721

Editor:
Orion Company
Communication
Orionintie 1A, FI-02200 Espoo, Finland
www.orion.fi

Orion is a Finnish pharmaceutical company operating globally – a wellness builder. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is constantly developing new drugs and treatment methods. The main therapeutic areas of Orion’s pharmaceutical R&D are neurological disorders, oncology and respiratory diseases for which Orion develops inhaled pulmonary drugs. Orion’s net sales in 2020 were € 1,078 million and the company had approximately 3,300 employees at the end of the year. Orion’s A and B shares are listed on Nasdaq Helsinki.


Source link

Comments are closed.